Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Adeline Palisse | Researchclopedia

Back to researchers

Adeline Palisse

Galapagos (Belgium)ORCID

20

Works

219

Citations

7

h-index

6

i10-index

Research Topics

Catalytic Alkyne Reactions Catalytic C–H Functionalization Methods Cyclopropane Reaction Mechanisms

Affiliations

Target (United States)2025–2025

University of Wuppertal2012–2015

AstraZeneca (Netherlands)2024–2025

AstraZeneca (Poland)2024–2025

Institute of Medicinal Plant Development2024–2024

Top Works

Metal-free reactions of alkynes via electrophilic iodocarbocyclizations

Adeline Palisse,Stefan F. Kirsch

201271 citations

Cell death mechanisms and regulation

Hepatitis B Virus Studies

Domino Reactions Consisting of Heterocyclization and 1,2‐Migration—Redox‐Neutral and Oxidative Transition‐Metal Catalysis

Klaus‐Daniel Umland,Adeline Palisse,et al.

201142 citations

Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis

Oscar Mammoliti,Adeline Palisse,et al.

202130 citations

Synthesis of Furans through Silver‐Catalyzed Propargyl–Claisen Rearrangement Followed by Cyclocondensation

Adeline Palisse,Stefan F. Kirsch

201422 citations

Discovery and Optimization of Orally Bioavailable Phthalazone and Cinnolone Carboxylic Acid Derivatives as S1P2 Antagonists against Fibrotic Diseases

Oscar Mammoliti,Koen Jansen,et al.

202120 citations

Dominoreaktionen bestehend aus Heterocyclisierung und 1,2‐Verschiebung – redoxneutrale und oxidative Übergangsmetallkatalyse im Vergleich

Klaus‐Daniel Umland,Adeline Palisse,et al.

201115 citations

Discovery of GLPG2737, a Potent Type 2 Corrector of CFTR for the Treatment of Cystic Fibrosis in Combination with a Potentiator and a Type 1 Co-corrector

Mathieu Pizzonero,Rhalid Akkari,et al.

20248 citations

Structure-Based Optimization of a Series of Covalent, Cell Active Bfl-1 Inhibitors

Simon C. C. Lucas,J. Henry Blackwell,et al.

20247 citations

Structure-Based Discovery of a Series of Covalent, Orally Bioavailable, and Selective BFL1 Inhibitors

Adeline Palisse,Tony Cheung,et al.

20243 citations